14 Jun 2013

Olsson to face Fernandez in Olot

Match Report

Photo: Fundacio Tommy RobredoStefan Olsson (SWE)

Defending champion Stefan Olsson faces the biggest threat yet to his unbeaten record at the Open Memorial Santi Silvas, part of the NEC Wheelchair Tennis Tour, when he plays world No. 5 Gustavo Fernandez of Argentina in Saturday’s men’s singles semifinals.

World No. 9 Olsson is bidding for his fifth successive title this year in Olot and the third seed moved into the last four after beating his fellow Swede Dan Wallin 62 63.

Olsson and Fernandez have won one match apiece in their only two meetings to date, Fernandez having come through in three close sets at the Florida Open in 2012. Top seed Fernandez earned his latest contest against two-time NEC Wheelchair Tennis Masters champion Olsson after racing past Switzerland’s Daniel Pellegrina 60 61.

Both men’s quarterfinals in the bottom half of the draw ended in straight sets wins, too, as second seed Joachim Gerard defeated Italy's Fabian Mazzei 61 62. The Belgian, a recent finalist at the Japan Open, will now play Dutch fourth seed Tom Egberink, who ended the Spanish challenge after a 61 64 win over Roberto Chamizo.

Cabrillana edges Helouin in women’s singles

While Fernandez moved into the men’s singles semifinals, fellow South American Macarena Cabrillana secured a notable victory when the Chilean clinched victory in a final set tiebreak in her second match of the week.

After a first day loss to world No. 1 Aniek van Koot, Cabrillana sealed a 63 57 76(1) victory over Frenchwoman Pauline Helouin, with Helouin set to face van Koot in the final set of round-robin matches.

While Egberink beat Chamizo, van Koot secured another Dutch win over a Spanish opponent as the top seed maintained her bid for her second title at the ITF 2 Series tournament organised by ITF Wheelchair Tennis Ambassador Tommy Robredo and his Foundation.

Van Koot defeated Spain Lola Ochoa 61 61 in her second match of the week and has now dropped just four games in her first two contests.